Product Name: EBAG9 Antibody
Species Reactivity: Human
Tested Applications: WB
Applications: For WB starting dilution is: 1:1000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 24 kDa
Immunogen: This EBAG9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 88-117 amino acids from the Central region of human EBAG9.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 372196-77-5
Product: PIK-75
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Receptor-binding cancer antigen expressed on SiSo cells, Cancer-associated surface antigen RCAS1, Estrogen receptor-binding fragment-associated gene 9 protein, EBAG9, RCAS1
Accession NO.: O00559
Protein Ino:
Official Symbol: EBAG9
Geneid: 9166
Background: This gene was identified as an estrogen-responsive gene.Regulation of transcription by estrogen is mediated by estrogenreceptor which binds to the estrogen-responsive element (ERE) foundin the 5-flanking region of this gene. The encoded protein is atumor-associated antigen that is expressed at high frequency in avariety of cancers. Two transcript variants differing in the 5UTR, but encoding the same protein, have been identified for thisgene.
PubMed ID:http://aac.asm.org/content/39/3/771.abstract
